These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 364725)

  • 1. Differential effects of immunosuppressive agents on human lymphocyte subpopulations: suppressive agent and individual recipient variables.
    Thomas FT; Thomas JM; Lower RR; Mendez G; Lee HM
    Surg Forum; 1977; 28():325-7. PubMed ID: 364725
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of immunosuppressive agents on T and B lymphocytes.
    Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM
    Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antilymphocyte serum (ALS) as immunosuppressive agent].
    Piardi W
    Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of anti-lymphocyte serum on various types of lymphocytes in intact dogs and in dogs with an allotransplanted kidney].
    Bilenko MV; Dreval' AA; Bogdanova VI; Zhukov NG
    Eksp Khir Anesteziol; 1971; 16(3):3-11. PubMed ID: 4939928
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
    Levey RH; Parkman R
    Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro test of the immunosuppressive activity of antilymphocyte serum.
    Möller G; Lundgren G; Balner H
    Transplantation; 1970 Feb; 9(2):166-8. PubMed ID: 4984355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antilymphocyte serum: choice of antigen for its preparation and immunosuppression tests].
    Traeger J; Fries D; Perrin J; Saubier E; Revillard JP; Brochier J; Dubernard JM; Carraz M; Plan M; Archimbaud JP
    J Urol Nephrol (Paris); 1969 Sep; 75(9):584-9. PubMed ID: 4997175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological problems in organ transplantation (with reference to oncology)].
    Gazzera G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with antilymphocyte globulin in kidney transplants].
    Largiadèr F; Linder E; Scheitlin W; Senning A
    Helv Chir Acta; 1970 Apr; 37(1):34-9. PubMed ID: 4939948
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of immunosuppressive drugs on human T, B, and K lymphocytes.
    Thomas F; Thomas J; Mendez G; Lower R; Lee HM
    Transplantation; 1977 Dec; 24(6):435-41. PubMed ID: 339440
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.
    Yoon YS; Cheigh JS; Riggio RR; Stenzel KH; Suthanthiran M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1925. PubMed ID: 2652626
    [No Abstract]   [Full Text] [Related]  

  • 14. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 15. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
    Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of some immunosuppressive substances on the lymphocytic membrane].
    Beretta Anguissola A; Lajolo Di Cossano D; Pecco P; Bert G
    Minerva Med; 1970 Jul; 61(55):3028-31. PubMed ID: 5427677
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression with antilymphocyte globulin in clinical renal transplantation.
    Konomi K; Deodhar SD; Tung KS; Nakamoto S
    Surg Forum; 1968; 19():194-5. PubMed ID: 4887905
    [No Abstract]   [Full Text] [Related]  

  • 20. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.